Peter Horby @peterhorby.bsky.social

Moh Family Foundation Professor of Emerging Infections and Global Health. Director, Pandemic Sciences Institute, University of Oxford, UK.

[Peter Horby @peterhorby.bsky.social @PeterHorby]

PSI Director calls for stronger pandemic intelligence after UK Covid-19 Inquiry Module 2 report published https://t.co/vjbcUkVFhR

[Peter Horby @peterhorby.bsky.social @PeterHorby]

Want to make a meaningful impact in global health security?
DPhil (PhD) in infection prevention control and biocontainment measures for high consequence infectious diseases. https://t.co/YRD88214rK
⏰ Application deadline: 10th October, 5pm UK time. Jan 2026 start!

[MORU @MORUBKK]

Simple new method that measures viral clearance means promising antibody treatments for #Covid & flu can be quickly assessed for effectiveness, say researchers in @TheLancet, & save time, money, lives in next pandemic
https://t.co/PxN74Lv0ni

Full paper: https://t.co/k1MKnznLLm

[London School of Hygiene & Tropical Medicine @LSHTM]

World’s first rigorous clinical trial of treatments for bubonic #plague:

UK & #Madagascar researchers find treatment at home with oral antibiotics highly effective & safe low-cost alternative to injections
👉https://t.co/pspdXg3LmK

[Peter Horby @peterhorby.bsky.social @PeterHorby]

Fantastic to see this published - first ever trial of treatment for bubonic plague

Huge thanks to the wonderful team in Madagascar #InstitutPasteur and our funders #FCDO #Wellcome

An important but incredibly challenging study - everyone deserves to benefit from science.

[NEJM @NEJM]

Data on treatments for bubonic plague are limited. In this open-label, randomized, controlled trial in Madagascar, ciprofloxacin monotherapy was noninferior to a standard aminoglycoside–ciprofloxacin regimen. Full IMASOY trial results and Research Summary: https://t.co/N42b8KPRxE

[Peter Horby @peterhorby.bsky.social @PeterHorby]

Fantastic morning discussing pandemic prevention, One Health and system-wide approaches. Now debating the Pandemic Agreement and what it means in practice. https://t.co/Oo2dAJLTmw

[Nuffield Department of Medicine @NDMOxford]

In a collaborative new study, researchers at @PSIOxford have partnered with global colleagues to discover how #AI could accelerate infectious disease research and help to prepare the world for the next pandemic 🔬🦠🤖

Find out more 👉 https://t.co/imgcNuq5FK

[remap-cap @remap_cap]

REMAP-CAP's @DerdeLennie adds her voice to a beautiful celebration of #InternationalDayofWomenandGirlsinScience 👇

[ALERRT @ALERRT_Global]

New publication in The Lancet: Epidemiological and clinical features of mpox during the clade Ib outbreak in South Kivu. A prospective observational cohort study at Kamituga General Hospital.
https://t.co/A8fE2c4eq1

[Peter Horby @peterhorby.bsky.social @PeterHorby]

There seem to be THREE simultaneous filovirus outbreaks - Marburg in Tanzania, Ebola in DRC (most likely culprit Zaire Ebolavirus) and Sudan Ebolavirus in Uganda.

We need adequately funded public health and research and development programmes and support.

[Ministry of Health- Uganda @MinofHealthUG]

Permanent Secretary, Dr. @DianaAtwine addresses the media this afternoon.

“An outbreak of Sudan Ebola Virus Disease has been confirmed in Kampala, Uganda following confirmation from 3 National Reference Laboratories.”

[Peter Horby @peterhorby.bsky.social @PeterHorby]

Although sotrovimab likely to have no useful activity against current SARS-CoV-2 variants, these data, along with the RECOVERY casirivimab-imdevimab
result, show that mAbs which effectively neutralise can benefit some hospitalised patients.

[Peter Horby @peterhorby.bsky.social @PeterHorby]

🔥 RECOVERY sotrovimab result now available.
Despite widespread vaccination and natural immunity, sotrovimab reduced mortality in COVID-19 inpatients with high levels of SARS-CoV-2 antigen.

https://t.co/24mEvmhcrW

[WHO African Region @WHOAFRO]

As #Tanzania responds to the confirmed outbreak of #Marburg virus disease, @WHO is working closely with the national health authorities to reinforce control measures to halt the outbreak as soon as possible and protect the health of the population.

https://t.co/bjxigRDltB

[Peter Horby @peterhorby.bsky.social @PeterHorby]

Marburg raises its head again: so soon after Rwanda outbreak. There are no approved treatments or vaccines for Marburg - from each outbreak we need to incrementally gather the data we need for effective control and treatment.

[World Health Organization (WHO) @WHO]

WHO informed its Member States and International Health Regulation State Parties of an outbreak of suspected Marburg Virus Disease in the Kagera region of #Tanzania

So far, we are aware of 9 suspected cases incl. 8 deaths across 2 districts.

WHO risk assessment of this suspected outbreak:
National level: High
Regional level: High
Global level: Low

More https://t.co/CnqFtmpkI9

[Peter Horby @peterhorby.bsky.social @PeterHorby]

Controversial COVID study that promoted unproven treatment retracted after four-year saga https://t.co/BFLsOIvZA4

Ironic that the co-authors complain they were “victims of cyber-harassment” - they should try being on the receiving end of HCQ believers, including Raoult himself.

[Peter Horby @peterhorby.bsky.social @PeterHorby]

An extraordinarily strong lesson on the importance of good science, critical thinking, and being truly objective.
The damage done to trust and to patients by the hydroxycholoroquine debacle should never be repeated.
Would love to know the reasons for retraction.

[Martin Landray @MartinLandray]

Extraordinary: Raoult’s damaging paper on hydroxychloroquine for COVID-19 finally retracted.

So grateful to all the people who helped with the RECOVERY trial, allowing us to debunk the myth of hydroxychloroquine for severe COVID-19

https://t.co/tguJN6QgtF

[Martin Landray @MartinLandray]

Extraordinary: Raoult’s damaging paper on hydroxychloroquine for COVID-19 finally retracted.

So grateful to all the people who helped with the RECOVERY trial, allowing us to debunk the myth of hydroxychloroquine for severe COVID-19

https://t.co/tguJN6QgtF

[Peter Horby @peterhorby.bsky.social @PeterHorby]

Md Zakiul Hassan recognised as 2024 ISID Emerging Leader https://t.co/3vt38wDFef

[Peter Horby @peterhorby.bsky.social @PeterHorby]

Influenza going up in the UK. For those involved in the RECOVERY trial of influenza treatments - please try to enrol patients. If this season is short and sharp, we will have a limited time window for recruitment.